According to the National Institute of Mental Health, schizophrenia is a chronic, severe, and disabling brain disorder that affects about 1% of Americans. Schizophrenia often causes paranoia, hearing voices other people don't hear, and believing other people are reading their minds, controlling their thoughts, or plotting to harm them.Read More
Science Market Update
Tags: CA, neurodevelopmental disorders, California, 2015, UCDMC, BioResearch Product Faire Event, Neurology, Sacramento, Davis, NIH funding, new Building, research grants, NIH grants, UC Davis, best lab supply tradeshows, best science tradeshows
Two prominent researchers at UC Davis are under a microscope for their work in stem-cell biotechnology. The pair from University of California, Davis was awarded close to $4 million in funding to improve biotechnology intended for physicians studying stem cell treatments.
The two grant awards, of over $1.8 million each, were awarded to Laura Marcu and Kent Leach by the California Institute for Regenerative Medicine (CIRM) to continue developing technology that is used in stem cell treatments for vascular disease, bone and cartilage repair.Read More
The American Society for Microbiology released a study that showed some interesting results about whether or not people are actually washing their hands. Here are some results of the findings.Read More
Sugar-sweetened soda consumption might promote disease independently from its role in obesity, according to UC San Francisco researchers who found in a new study that drinking sugary drinks was associated with cell aging.Read More
Tags: California, 2015, San Diego, UCDMC, San Francisco, UCSD, UC San Diego, UCSF, Sacramento, UC San Francisco, UC Davis - Medical Center, Northern California BioResearch, San Francisco at Mission Bay, San Francisco Bay Area
Researchers at UC Davis and other institutions have found that diets rich in whole walnuts or walnut oil, slowed prostate cancer growth in mice. In addition, both walnuts and walnut oil reduced cholesterol and increased insulin sensitivity (when you have high insulin sensitivity, you are able to eat carbohydrates without such a large rise in insulin. When insulin is kept low enough, fatty acids can still be released). The walnut diet also reduced levels of the hormone IGF-1, which had been previously implicated in both prostate and breast cancer. The study was published online in the Journal of Medicinal Food.Read More
There are many times when putting tarantula toxin into human cells seems like a very bad idea. At the University of California, Davis, however, it is a breakthrough idea that allows for closer examination of the electrical activity in cells, especially neurons. This opens up the field of brain study and also lends insights into conditions like muscle defects, cardiac arrhythmias, and epilepsy.Read More
This prestigious designation makes the MIND Institute one of only fifteen Intellectual and Developmental Disabilities Research Centers in the country. Transition into this program is made possible by a five-year $6.5 million NIH grant and gives the institute critical new resources that will accelerate its progress in neurodevelopment research.
Tags: University of California Davis Medical Center, Bioinformatics, neurodevelopmental disorders, assays, molecular biology imaging, biological analysis, immunoassays, environmental contaminants, Autism, UCDMC, Funding, Research, NIH, UC Davis, UCD, grant, drug evaluation, developmental disabilities
Researchers at the University of California, Davis Cancer Center recently received $3 million in UC Davis life science funding from the National Cancer Institute, a part of the NIH. The project leader, Dr. De Vere White, targets his research to focus on prostate and bladder cancers. In addition Dr. De Vere has received continual NCI funding for this research since 1985.
The NIH has just announced $5.3M in two new awards through the Autism Centers of Excellence (ACE) program to support autism research studies led by two University of California investigative teams, at UCLA and the UC Davis Medical Center MIND Institute. ACE funding is earmarked for large, multi-disciplinary studies into the origins of autism spectrum neurological disorders and avenues for their treatment. In the case of the two latest awardees, one is a clinical behavioral study and one is a study of genetic variants. The $5.3M is initial one-year funding, with extensions of up to five years. The ACE program includes both centers and networks. Centers are made up of multiple investigators at one site working together on a specific research problem; networks include investigative teams from different sites engaged in a focused study. Both UCLA and UC Davis are ACE centers and will lead the current research projects, though in collaboration with colleagues at other research institutions, namely Harvard, UW, Vanderbilt, Emory, Johns Hopkins, and Yale. As with all ACE research, data and findings are collected centrally by the NIH to maximize their availability to the larger research community.
Tags: 2014, CA, 2013, Southwest, Los Angeles, Autism, LAVS, UCDMC, BioResearch Product Faire Event, Funding, UCLA, Genetics, Research, Sacramento, Davis, NIH funding, UC Los Angeles, UC Davis, Biotechnology Vendor Showcase Event